Skip to content
Brand AI

Excision BioTherapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Excision BioTherapeutics completes $60 million financing

    Excision BioTherapeutics announced completion of a $60 million financing to advance its lead candidate EBT-101 into a Phase 1/2 clinical trial and support preclinical programs.

    Source